Cost-effectiveness analysis of fruquintinib as third-line treatment for patients with metastatic colorectal cancer

Zhang, PF; Xie, D; Li, Q

Li, Q (corresponding author), Sichuan Univ, Dept Med Oncol, Ctr Canc, West China Hosp, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.; Li, Q (corresponding author), Sichuan Univ, West China Biomed Big Data Ctr, West China Hosp, West China Sch Med, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.

TUMORI J, 2020; 106 (5): 400

Abstract

Objective: To evaluate the cost-effectiveness of addition of fruquintinib to best supportive care (BSC) in third-line treatment for patients with meta......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索